ImageneBio Inc (IMA)

• Market cap: $59.7M
• 1 day: -10.49%
• 5 days: -6.54%
• 1 month: 15.75%
• 3 months: -28.13%
• 6 months: -35.49%
• Year to date: -21.75%
• 1 year: -59.18%
• 5 years: -98.02%
• 10 years: -98.62%
• Sector: Healthcare
• Industry: Biotechnology

About: ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.

Employees: 15